FDA panel backs 4 unapproved peptides as experts warn about online sourcing risks Dallas peptide company founder and Baylor Scott and White physician weigh in on a growing gray market WACO, Texas (KWTX) - An FDA advisory panel on Thursday and Friday voted to support allowing pharmacies to compound four unapproved peptides BPC-157, KPV, TB-500 and MOTS-C as the compounds continue to be sold online and self-administered at home
- Pregnancy and breast-feeding: As there is no established safety data for MOTS-c use during pregnancy or breast-feeding, it should be avoided
PubMed PMID 30915550 review of BPC-157 in musculoskeletal soft-tissue research, emphasizing that most evidence comes from small-animal models
Given the critical roles that vitamin B12 plays within the body, a deficiency can have serious health consequences
Bring your prescription into the pharmacy and our accredited pharmacists can administer the dose for you
In these cases, intravenous B12 administration via injection is not just preferable it is essential